CXCL10 and neoplasm: Based on this mechanism, it is believed that IL-18 and IP-10/CXCL10 do not exert tumor-suppressive effects, but rather, promote IFN-γ secretion and chemoattraction of CXCR3+ cells into the NPC TME.